Schrödinger faces financial losses amid investment in experimental drugs. Key 2025 trial results will reveal its future ...
The American Cancer Society's chief scientific officer outlines the group's research agenda, including a new project in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback